Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors

This publication has 18 references indexed in Scilit:

• Targeting the c-Met Signaling Pathway in Cancer
  Clinical Cancer Research, 2006
• Hepatocyte growth factor, its receptor, and their potential value in cancer therapies
  Critical Reviews in Oncology/Hematology, 2005
• Hepatocyte growth factor/c-metsignaling pathway is required for efficient liver regeneration and repair
  Proceedings of the National Academy of Sciences, 2004
• Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
  Cytokine & Growth Factor Reviews, 2002
• Expression of the hepatocyte growth factor/c‐Met pathway is increased at the cancer front in breast carcinoma
  Pathology International, 2001
• Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
  Trends in Cell Biology, 1998
• Roles of mesenchymal-epithelial interactions and hepatocyte growth factor-scatter factor (HGF-SF) in placental development
  Reviews of Reproduction, 1996
• Acquisition of Invasive Phenotype in Gallbladder Cancer Cells via Mutual Interaction of Stromal Fibroblasts and Cancer Cells as Mediated by Hepatocyte Growth Factor
  Japanese Journal of Cancer Research, 1996
• Enhanced Tumorigenicity and Invasion-Metastasis by Hepatocyte Growth Factor/Scatter Factor-Met Signalling in Human Cells Concomitant with Induction of the Urokinase Proteolysis Network
  Molecular and Cellular Biology, 1996
• Overexpression of theMET/HGF receptor in ovarian cancer
  International Journal of Cancer, 1994